Press Release Feel the charm of exquisite city, promote economic and trade cooperation with Nicaragua between enterprises WEIHAI, China, Dec. 6, 2023 /PRNewswire/ — A report from dzwww.com: jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=” … CISION PRNewswireDecember 6, 2023
Press Release Tech TV360 Acquires Exclusive Broadcasting Rights For Euro 2024 HANOI, Vietnam, Dec. 6, 2023 /PRNewswire/ — Viettel Telecom, the leading telecommunications… CISION PRNewswireDecember 6, 2023
Business Press Release WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader SUZHOU, China, Dec. 6, 2023 /PRNewswire/ — WuXi Vaccines, a leading global… CISION PRNewswireDecember 6, 2023
Business Press Release Tech VERTICAL INSTITUTE REVOLUTIONISES CAREER DEVELOPMENT WITH CUTTING-EDGE COURSES AND EXPERT-LED INSTRUCTION Vertical Institute (VI) is a leading provider of cutting-edge courses, addressing the… CISION PRNewswireDecember 6, 2023
Press Release Antengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma XPOVIO® (selinexor) is the first and only exportin 1 (XPO1) inhibitor approved… CISION PRNewswireDecember 6, 2023
Press Release Qilu Pharmaceutical Announces Results from Phase II Study for iparomlimab for Advanced Solid Tumors at ESMO Asia, with an ORR of 45.8% JINAN, China, Dec. 6, 2023 /PRNewswire/ — Qilu Pharmaceutical presented the latest… CISION PRNewswireDecember 6, 2023
Press Release Koselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas KUALA LUMPUR, Malaysia, Dec. 6, 2023 /PRNewswire/ — AstraZeneca’s Koselugo (selumetinib) is… CISION PRNewswireDecember 6, 2023
Press Release Tech OKX Ventures Joins Ethereum Climate Platform As a Launch Partner to Advance Sustainability in Web3 SINGAPORE, Dec. 6, 2023 /PRNewswire/ — OKX Ventures, the investment arm of… CISION PRNewswireDecember 6, 2023
